Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

Evaluation of Galcanezumab in the Prevention of Chronic Migraine

ClinicalTrials.gov ID: NCT02614261

Public ClinicalTrials.gov record NCT02614261. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 25, 2026, 11:44 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of LY2951742 in Patients With Chronic Migraine - the REGAIN Study

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The main purpose of this study is to evaluate the efficacy of the study drug known as galcanezumab in participants with chronic migraine.

Study identification

NCT ID
NCT02614261
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Eli Lilly and Company
Industry
Enrollment
1,117 participants

Conditions and interventions

Interventions

Drug

Eligibility (public fields only)

Age range
18 Years to 65 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Nov 30, 2015 (Actual)
Primary completion
Mar 16, 2017 (Actual)
Completion
Jul 14, 2021 (Actual)
Last update posted
May 18, 2022

2015 – 2021

United States locations

U.S. sites
52
U.S. states
26
U.S. cities
50
Facility City State ZIP Site status
21st Century Neurology Phoenix Arizona 85004 —
Arizona Research Center Phoenix Arizona 85023 —
Pharmacology Research Institute, Encino Encino California 91316 —
Fullerton Neurology and Headache Center Fullerton California 92835 —
Pharmacology Research Institute, Los Alamitos Los Alamitos California 90720 —
Pharmacology Research Institute, Newport Beach Newport Beach California 92660 —
Desert Valley Research Rancho Mirage California 92270 —
Anderson Clinical Research Redlands California 92374 —
Artemis Institute for Clinical Research San Diego California 92103 —
Medical Center for Clinical Research San Diego California 92108 —
Optimus Medical Group San Francisco California 94102 —
Colorado Neurological Institute Englewood Colorado 80113 —
Advanced Neurosciences Research, LLC Fort Collins Colorado 80528 —
Associated Neurologists of Southern Connecticut Fairfield Connecticut 06824 —
Avail Clinical Research LLC DeLand Florida 32720 —
Clinical Neuroscience Solutions Inc Jacksonville Florida 32256 —
|Renstar Medical Research Ocala Florida 34471 —
Psychiatric Inst of Florida-Clinical Neuroscience Solutions Orlando Florida 32801 —
Compass Research Oviedo Florida 32765 —
Premiere Research Institute at Palm Beach Neurology West Palm Beach Florida 33407 —
Northwest Clinical Trials Boise Idaho 83704 —
Christie Clinic, LLC Champaign Illinois 61820 —
Robbins Headache Clinic Riverwoods Illinois 60015 —
Midwest Institute for Clinical Research Indianapolis Indiana 46260 —
Phoenix Medical Research, Inc Prairie Village Kansas 66208 —
Heartland Research Associates Wichita Kansas 67205 —
PharmaSite Research Inc Baltimore Maryland 21208 —
Boston Clinical Trials Inc Boston Massachusetts 02131 —
Michigan Head, Pain and Neurological Institute Ann Arbor Michigan 48104 —
Clinical Research Institute Minneapolis Minnesota 55402 —
Healthcare Research Network - Hazelwood Hazelwood Missouri 63042 —
ClinVest Springfield Missouri 65807 —
Albuquerque Clinical Trials Albuquerque New Mexico 87102 —
Dent Neurological Institute Amherst New York 14226 —
Island Neuro Associates,PC Plainview New York 11803 —
Univ of Cincinnati College of Medicine Cincinnati Ohio 45219 —
Healthcare Research Consultant Tulsa Oklahoma 74135 —
Preferred Primary Care Physicians Pleasant Hills Pennsylvania 15236 —
Abington Neurological Associates Willow Grove Pennsylvania 19090 —
Clinical Trials of South Carolina Charleston South Carolina 29406 —
University of South Carolina Columbia South Carolina 29203 —
Coastal Carolina Research Center, Inc. Mt. Pleasant South Carolina 29464 —
BG Neurology Spartanburg South Carolina 29307 —
ClinSearch Chattanooga Tennessee 37421 —
FutureSearch Trials of Neurology and Sleep Lab Austin Texas 78731 —
Headache Medicine Specialist of North Texas Dallas Texas 75231 —
Foothill Family Clinic Salt Lake City Utah 84109 —
Health Research of Hampton Roads Inc Newport News Virginia 23606 —
Sentara Neurology Specialists Virginia Beach Virginia 23456 —
Northwest Clinical Research Center Bellevue Washington 98007-4209 —
Premier Clinical Research Spokane Washington 99202 —
Dean Foundation for Health Research and Education Middleton Wisconsin 53562 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 65 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT02614261, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted May 18, 2022 · Synced Oct 25, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT02614261 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →